Acromegaly
NEJM 393:1926-1939, Giustina,A. & Colao,A.,, 2025
Aneurysmal Subarachnoid Hemorrhage
NEJM 354:387-396, Suarez,J.I.,et al, 2006
Brain Metastases
The Neurologist 10:31-46, Klos,K.J.&O'Neill,B.P., 2004
Restless Legs Syndrome, A Review
JAMA 335:703-714, Winkelmen,J.W. & Wipper, B., 2026
Calcitonin Gene-Related Peptide-Targeted Therapy in Migraine: Current Role and Future Perspectives
Lancet 405:1014-1026, Versijpt,J.,et al, 2025
Idiopathic Normal-Pressure Hydrocephalus
NEJM 393:2243-2253, 2264, Johnson,M.D.,& Williams, M.A., 2025
Neurologic Manifestations of Long COVID Differ Based on Acute COVID-19 Severity
Ann Neurol 94:146-159, Giraldo,G.S.P.,et al, 2023
Targeting Calcitonin Gene-Related Peptide: A New Era in Migraine Therapy
Lancet 394:1765-1774, Charles, A. & Pozo-Rosich, P., 2019
Muscular Dystrophies
Lancet 394:2025-2038, Mercuri, E.,et al, 2019
Subarachnoid Hemorrhage
NEJM 377:257-266, Lawton, M.T. & Vates, G.E., 2017
Practice Guideline Update Summary: Botulinum Neurotoxin for the Treatment of Blepharospasm, Cervical Dystonia, Adult Spasticity, and Headache
Neurol 86:1818-1826, Simpson, D.M.,et al, 2016
Myasthenia Gravis
NEJM 375:2570-2581, Gilhus, N.E.,et al, 2016
Low Prevalence of Neurocognitive Impairment in Early Diagnosed and Managed HIV-Infected Persons
Neurol 80:371-379, Crum-Cianflone, N.,et al, 2013
Tourettes Syndrome
BMJ 347:f4964, Cavanna, A.E. & Seri, S., 2013
Current Concepts and Management of Glioblastoma
Ann Neurol 70:9-21, Preusser, M.,et al, 2011
OnabotulinumtoxinA Improves Quality of Life and Reduces Impact of Chronic Migraine
Neurol 77:1465-1472, Lipton, R.B.,et al, 2011
Diagnosis and Management of Lumbar Spine Stenosis
JAMA 303:71-72, Haig,A. &Tomkins,C., 2010
Chronic Daily Headache With Analgesic Overuse
Neurol 62:1338-1342, Colas,R.,et al, 2004
Cerebral Palsy
Lancet 363:1619-1631, Koman,L.A.,et al, 2004
Quality of Life in Chronic Daily Headache
Neurol 58:1062-1065, Guitera,V.,et al, 2002
Migraine, Quality of Life, and Depression
Neurol 55:629-635,610, Lipton,R.B. et al, 2000
The Impact of Migraine on Quality of Life in the General Population
Neurol 55:624-629, 610, Terwindt,G.M. et al, 2000
Changes in Resource Use and Outcomes for Patients with Migraine Treated with Sumatriptan, A Managed Care Perspective
Arch Int Med 159:857-863, Lofland,J.H.,et al, 1999
Recurrent Migraine:Cost-Effective Care
Neurol 44:S25-S28, Rapoport,A.M., 1994
The Sleep Apnoea/Hypopnoea Syndrome and Snoring
BMJ 306:1057-1060, Douglas,N.J., 1993
Magnetic Resonance Imaging of the Head and Spine:Effective for the Clinician or the Patient
BMJ 302:78-82, Dixon,A.K.,et al, 1991
Cost Effectiveness of Magnetic Resonance Imaging in the Neurosciences
BMJ 303:1435-1439, Szczepura,A.K.,et al, 1991